Stocktoria
OneMedNet Corp ONMD
Nasdaq · stock · Services-Commercial Physical & Biological Research · website · IPO 2021-05-07
OneMedNet Corp financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $1.4M | $643,000 | $1.0M | $1.2M |
| Gross profit | -$503,000 | -$281,000 | -$129,000 | -$360,690 |
| R&D expense | $1.5M | $1.5M | $2.1M | $952,701 |
| Operating income | -$9.7M | -$9.6M | -$6.9M | -$11.4M |
| Interest expense | — | — | $749,213 | $403,307 |
| Income tax | $1,000 | $2,000 | $18,000 | $214,850 |
| Net income | -$2.8M | -$10.1M | -$33.8M | -$6.2M |
| EPS (diluted) | $-0.06 | $-0.36 | $-4.65 | $0.03 |
| Operating cash flow | -$7.5M | -$7.0M | -$4.8M | $87.2M |
| Free cash flow | -$7.5M | -$7.0M | -$4.8M | $87.2M |
| Cash & equivalents | $585,000 | $172,000 | $47,000 | $301,730 |
| Total assets | $2.2M | $3.7M | $464,000 | $30.4M |
| Total liabilities | $5.1M | $19.7M | $13.9M | $21.2M |
| Shareholders' equity | -$3.0M | -$15.9M | -$13.4M | -$26.4M |
Growth · year-over-year · Revenue CAGR 5.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +111.4% | -37.0% | -11.4% | — |
| EPS growth | — | — | -15600.0% | — |
| Free cash flow growth | — | — | -105.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.